Extended Thromboprophylaxis With Betrixaban or Rivaroxaban for Acutely Ill Hospitalized Medical Patients: Meta-Analysis of Prespecified Subgroups.

Jamil, Adeel; Jamil, Umer; Singh, Kamaldeep; Khan, Faris; Chi, Gerald

Jamil, Adeel; Jamil, Umer; Singh, Kamaldeep; Khan, Faris; Chi, Gerald.

Afiliação

Jamil A; From the Department of Medicine, OSF Healthcare St. Francis Medical Center, Peoria, IL.
Jamil U; From the Department of Medicine, OSF Healthcare St. Francis Medical Center, Peoria, IL.
Singh K; Department of Medicine, Division of Inpatient Medicine, Banner University Medical Center, Medical Center, University of Arizona College of Medicine, Tucson, AZ.
Khan F; Department of Medicine, Division of Cardiology, University of Nebraska Medical Center, Omaha, NE; and.
Chi G; Department of Medicine, Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

Crit Pathw Cardiol ; 20(1): 16-24, 2021 03 01.

Article em En | MEDLINE | ID: mdl-32657973

Assuntos

Rivaroxabana; Tromboembolia Venosa; Anticoagulantes; Benzamidas; Humanos; Piridinas; Fatores de Risco; Tromboembolia Venosa/prevenção & controle

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tromboembolia Venosa / Rivaroxabana Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google